Read a peptide COA by matching the lot first, then separating identity, chromatographic purity, measured content, and any microbial or endotoxin results. These tests answer different questions. For a current Retatrutide research peptide offering, compare the selected variation with its linked report and the public batch archive; a result from another lot does not automatically cover the vial being reviewed.
Literature and batch-document review: September 23, 2026. Laboratory research reference.
Start with the report number and the lot on the vial
Here is a check that can be made against a real BulkGLP archive entry. The Retatrutide 10 mg certificate, accession 2601130171, names product lot 062502. It records a January 13, 2026 received date and a January 15 reported date. The document names Bulk Nutrition Group as the client and Freedom Diagnostics as the testing laboratory. Those fields identify the report you are actually reading; “Retatrutide 10 mg” alone does not.
The archive pairs that certificate with a second certificate, accession 2601130172, for the same 062502 lot. It also lists a separate Retatrutide 10 mg report, 2605280328, for lot 062503. Both lots share the nominal 10 mg size; they do not share a lot identifier. If the vial or selected variation says 062503, the 062502 reports are historical context, not its lot documentation.
Save the complete file and record the report number, product description, lot, laboratory, and dates together. The BulkGLP batch archive labels these examples as prior reports. None of them, on its own, establishes which lot is currently offered or that every unit was individually tested. Check the actual vial and current product record before assigning any result to material in hand.
Separate the analytical questions
| Reported item | Question it addresses | Important limit |
|---|---|---|
| Identity / LC-MS | Is the analyzed material consistent with the stated molecular identity? | A mass match alone does not establish quantity or prove every structural detail. |
| HPLC purity | What fraction of the integrated chromatographic response is assigned to the target? | Peak-area purity is not automatically a weight fraction or content per vial. |
| Quantitative content / assay | How much target material was measured on the stated basis? | Check units, calibration, sample basis and method. |
| Endotoxin | What endotoxin result was obtained under the reported method? | This is not the same test as sterility. |
| Sterility / microbial tests | What was observed for the tested sample and method? | Do not infer these results when the report omits them. |
| Lot and report identifiers | Which submitted material and document are being discussed? | A familiar product name alone does not establish lot coverage. |
Read the units and reporting basis beside each number. A result stated per milliliter cannot be treated as per vial without the relevant sample preparation and volume information. Similarly, “not detected” must be interpreted with the method’s detection or reporting limit; it does not mean a mathematically exact zero.
Read identity, purity and content as separate results
In report 2601130171 for lot 062502, the laboratory prints 10.96 mg under net peptide content and 99.53% under purity. Its chemical-analysis line states HPLC with UV detection coupled with mass spectrometry, and the identity field reads “GLP RT.” The content value is an amount; the purity value is a result on the report’s chromatographic basis; the identity entry addresses whether the analyzed material is consistent with the stated target. None is a substitute for the other two.
For comparison, the archive lists report 2605280328 for lot 062503 at 12.05 mg reported content and 99.76% purity. It is another nominal 10 mg Retatrutide option, yet the results and lot differ. Do not take 99.53% from one certificate and 12.05 mg from the other to construct a combined claim. Nor does multiplying a purity percentage by a content amount establish what is inside every vial: the measurements answer different questions about submitted samples.
When reviewing another COA, find its method, units and sample basis before comparing values. An HPLC peak-area percentage is not automatically a percentage of powder weight, and a mass-spectrometry match is not a quantitative assay. The report’s identity field is the laboratory’s result under its stated method; it does not prove every structural detail or every unit of a lot. Keep the report’s wording and the lot identifier attached to each number.
What LC-MS and molecular-mass results mean
Liquid chromatography coupled to mass spectrometry can connect a chromatographic component with measured ion signals. A peptide may appear in more than one charge state; the reported molecular mass may therefore involve interpretation or deconvolution rather than simply copying the largest displayed mass-to-charge number.
Compare the measured value with the expected chemical form and the laboratory’s stated tolerance. Modifications, salts, adducts, and the chosen reporting basis can affect how values should be read. Ask for the laboratory’s interpretation when the apparent match is unclear instead of trying to repair an unexplained discrepancy in a spreadsheet.
A matching mass supports identity but does not by itself prove sequence, exclude every isomer, or measure total material per container. Additional evidence may be needed for the intended question. ICH Q6A makes the related distinction that a chromatographic retention time alone is not sufficiently specific as an identity test.
Keep measured content separate from purity
A quantitative content result should identify the analyte, units, sample basis, and method used. For a vial-based result, understand whether the laboratory analyzed a whole submitted vial, an aliquot, a solution prepared by the submitter, or a pooled sample. Those are different sample histories.
A nominal label amount and a measured sample result can both be recorded without treating them as interchangeable. Record the label claim as the commercial presentation and the analytical value on its stated basis. Water, counterions, and disclosed excipients can make total solid weight different from peptide content.
When purchasing multiple containers, do not multiply a single submitted vial’s measured excess across every unit as a guaranteed quantity. Ask what sampling and quantitative evidence support the lot. If content is essential to the experiment, define the required evidence before treating the material as accepted inventory.
Read the separate endotoxin report without borrowing its result
The endotoxin certificate 2601130172 names Retatrutide 10 mg, lot 062502, just like purity-and-identity certificate 2601130171. It reports two replicate results, each ≤ 0.05 EU/mL and marked Pass; the document says the analysis was conducted in duplicate in accordance with USP <85> guidelines. That is the reported result and unit. Rephrasing it as “zero endotoxin” would erase the threshold shown on the document.
This second file does not report a sterility test. It also cannot supply an endotoxin finding for the other archived 10 mg lot, 062503. The matching compound and vial size are insufficient to move a result across lot numbers. When a researcher reviews a different lot, the useful record is the endotoxin document, if any, that actually names that lot; if none is available in the material reviewed, note that the evidence is missing rather than importing 062502’s “Pass.”
Keep the distinction among test categories explicit in the laboratory record: 2601130171 supplies reported identity, purity and content for its submitted sample; 2601130172 supplies the stated endotoxin result for the same named lot. Neither report establishes sterility, clinical suitability, a shelf life after reconstitution, or a result for future lots.
Evaluate the laboratory and report trail
Check that the testing laboratory can be identified independently from the supplier’s product page. Where a report-verification link or identifier is provided, use it and preserve the result. A cropped image of one number is less informative than the complete report and its traceable identifier.
ISO/IEC 17025 concerns testing and calibration laboratory competence. If accreditation is claimed, check the current certificate and relevant scope with the accreditation body; a logo alone does not show that every method on a report is covered. Do not describe a supplier itself as accredited merely because it uses an outside laboratory.
For a result that affects an important research decision, resolve discrepancies in writing. A useful question identifies the exact report, sample, field, and uncertainty. Keep the laboratory or supplier response with the original file rather than rewriting the report yourself.
Use a short COA review worksheet
- Identify the product, variation, lot and received or offered material.
- Save the complete report, laboratory identity, report number and version.
- Record identity, purity and content separately, including units and basis.
- Record additional tests exactly as reported, or mark them unreported.
- Compare results with the laboratory’s acceptance requirements.
- Resolve missing fields or conflicting identifiers with the supplier or laboratory.
- Document the acceptance decision and reviewer.
A COA review is strongest when another researcher can follow the same record and reach the same limited conclusion. The goal is not a blanket claim that a material is suitable for every purpose. It is a clear statement of what was tested, what the report supports, and what remains outside its scope.
A COA is one part of the material record
Connect the report to the peptide storage and shelf-life record. A sound report at one time does not erase a later storage excursion or establish an unlisted solution expiry. For procurement context, the Retatrutide sourcing guide explains how to request lot continuity and supporting documents before ordering.
Frequently asked questions
What is the first thing to check on a peptide COA?
Match the report to the actual compound, variation, and lot being reviewed. Then check the laboratory, report identifier, dates, methods, results, units, and all pages or revisions.
Does 99% HPLC purity mean 99% of the vial weight is peptide?
Not automatically. An area-normalized HPLC result describes the integrated detector response under that method. It does not by itself establish the peptide mass fraction or total content of a vial.
Does a mass-spectrometry match prove the amount in a vial?
No. Molecular-mass information supports identity. Quantity requires an appropriately quantitative measurement with its sample basis, units, and method.
What is the difference between purity and content?
Purity describes the result on the method’s stated purity basis, such as chromatographic peak area. Content measures an amount of the specified analyte. Record the two separately rather than substituting one for the other.
Is a low endotoxin result the same as sterility?
No. Endotoxin and sterility tests address different questions. Neither should be inferred from the other, and missing testing should be recorded as unreported.
Does not detected mean zero?
No. It means the method did not report the analyte above its applicable detection or reporting limit. Preserve the limit, units, and original result wording.
Can a report for one lot be used for a different lot?
Not without evidence that establishes the relevant coverage. A shared product name or formulation does not automatically connect a new lot to an earlier report.
Does a COA establish a peptide’s shelf life?
Only if the relevant stability claim is actually supported and applicable. A release result at one time is not a universal storage or solution-stability study.